Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin Tim EisenGunnar HedlundRobert Hawkins Evolving Therapies (R Bukowski, Section Editor) Open access 21 January 2014 Article: 370
Endoscopic Resection of Sinonasal Cancers Shirley Y. SuMichael E. KupfermanEhab Y. Hanna Head and Neck (E Hanna, Section Editor) 21 January 2014 Article: 369
Aflibercept—a Decoy VEGF Receptor Kristen K. CiomborJordan Berlin Evolving Therapies (R Bukowski, Section Editor) 21 January 2014 Article: 368
Etirinotecan Pegol: Development of a Novel Conjugated Topoisomerase I Inhibitor Carlos Alemany Evolving Therapies (R Bukowski, Section Editor) 21 January 2014 Article: 367
Resectable, Borderline Resectable, and Locally Advanced Pancreatic Cancer: What Does It Matter? Daniel M. HalperinGauri R. Varadhachary Gastrointestinal Cancers (B Czito, Section Editor) 21 January 2014 Article: 366
Endoglin for Targeted Cancer Treatment Lee S. RosenMichael S. GordonDaniela E. Matei Evolving Therapies (R Bukowski, Section Editor) 21 January 2014 Article: 365
Timing of Determining Axillary Lymph Node Status When Neoadjuvant Chemotherapy is Used Eleftherios P. Mamounas Breast Cancer (B Overmoyer, Section Editor) 21 January 2014 Article: 364